Jundishapur Journal of Microbiology

Published by: Kowsar

Comparison of the Antibacterial Effects of Nanosilver With 18 Antibiotics on Multidrug Resistance Clinical Isolates of Acinetobacter baumannii

Sarah Niakan 1 , Mohammad Niakan 2 , * , Saeed Hesaraki 3 , Mohammad Reza Nejadmoghaddam 4 , Mohammad Moradi 5 , Mojtaba Hanafiabdar 5 , Roya Allamezadeh 5 and Meysam Sabouri 4
Authors Information
1 Faculty of Specialized Veterinary Medicine Sciences and Research Branch, Islamic Azad University, Tehran, IR Iran
2 Department of Microbiology, Medicine Faculty, Shahed University, Tehran, IR Iran
3 Department of Pathology, Faculty of Specialized Veterinary medicine Sciences and Research Branch, Islamic Azad University, Tehran, IR Iran
4 Nanotechnology Research Center, School of Pharmacy Tehran university of Medical Sciences, Tehran, IR Iran
5 Shahed university student`s Research committee, Medical Faculty, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: July 01, 2013, 6 (5); e8341
  • Published Online: July 1, 2013
  • Article Type: Research Article
  • Received: September 30, 2012
  • Revised: February 10, 2013
  • Accepted: February 18, 2013
  • DOI: 10.5812/jjm.8341

To Cite: Niakan S, Niakan M, Hesaraki S, Nejadmoghaddam M R, Moradi M, et al. Comparison of the Antibacterial Effects of Nanosilver With 18 Antibiotics on Multidrug Resistance Clinical Isolates of Acinetobacter baumannii, Jundishapur J Microbiol. 2013 ; 6(5):e8341. doi: 10.5812/jjm.8341.

Copyright © 2013, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996; 9(2): 148-65[PubMed]
  • 2. Koneman EW, Allen DS, Janda M, Schreckenberger CP, Winn CW. Acinetobacter. 1992; : 213-15
  • 3. Jung JY, Park MS, Kim SE, Park BH, Son JY, Kim EY, et al. Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis. 2010; 10: 228[DOI][PubMed]
  • 4. Rahbar M, Hajia M. Detection and quantitation of the etiologic agents of ventilator-associated pneumonia in endotracheal tube aspirates from patients in Iran. Infect Control Hosp Epidemiol. 2006; 27(8): 884-5[DOI][PubMed]
  • 5. Chen D, Xi T, Bai J. Biological effects induced by nanosilver particles: in vivo study. Biomed Mater. 2007; 2(3)-8[DOI][PubMed]
  • 6. Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, et al. Antimicrobial effects of silver nanoparticles. Nanomedicine. 2007; 3(1): 95-101[DOI][PubMed]
  • 7. El-Ansary A, Al-Daihan S. On the toxicity of therapeutically used nanoparticles: an overview. J Toxicol. 2009; 2009
  • 8. Moeller K. Nano-Silver Proven Safe for Humans, American Biotech Labs. 2009;
  • 9. Panyala Nagender Reddy, Peña-Méndez Eladia María, Havel Josef. Silver or silver nanoparticles: a hazardous threat to the environment and human health. J. Appl. Biomed. 2008; 6(3): 117-129
  • 10. Constantiniu Sofia, Romaniuc Angela, Iancu Luminiţa Smaranda, Filimon Raluca, Taraşi Iuliana. Cultural and biochemical characteristics of Acinetobacter spp. Strains isolated from hospital units. J Prevent Med. 2004; 12: 35-42
  • 11. Performance standards for antimicrobial susceptibility testing; Twentieth informational supplement; M100-S20. 2010;
  • 12. Abbasi F, Yadegarynia D, Mardani M, Frasinejad B, Yaghubi T, Gholamin S. Emerging multi drug-resistant Acinetobacter in Iran: Study of 800 cases. Int J Infect Dis. 2010; 14
  • 13. Vahdani Parviz, Yaghoubi Tofigh, Aminzadeh Zohreh. Hospital acquired antibiotic-resistant Acinetobacter baumannii infections in a 400-bed hospital in Tehran, Iran. Int J Prevent Med. 2011; 2(3): 127
  • 14. Henwood CJ, Gatward T, Warner M, James D, Stockdale MW, Spence RP, et al. Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936). J Antimicrob Chemother. 2002; 49(3): 479-87[PubMed]
  • 15. Manikal VM, Landman D, Saurina G, Oydna E, Lal H, Quale J. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis. 2000; 31(1): 101-6[DOI][PubMed]
  • 16. Medic D, Ukropina MM, Gusman V, Jelesic Z, Milosavljevic B. [Carbapenems resistance of Acinetobacter spp strains isolated from wound swabs during 2009-2010]. Med Pregl. 2011; 64(11-12): 583-7[PubMed]
  • 17. Gaur A, Garg A, Prakash P, Anupurba S, Mohapatra TM. Observations on carbapenem resistance by minimum inhibitory concentration in nosocomial isolates of Acinetobacter species: an experience at a tertiary care hospital in North India. J Health Popul Nutr. 2008; 26(2): 183-8[PubMed]
  • 18. Dhabaan GhN, Hamimah H, Shorman MA. Emergence of extensive drug-resistant Acinetobacter baumannii in North of Jordan. Afr J Microbiol Res . 2011; 5(9): 1070-5
  • 19. Moniri R, Farahani RK, Shajari G, Shirazi MN, Ghasemi A. Molecular epidemiology of aminoglycosides resistance in acinetobacter spp. With emergence of multidrug-resistant strains. Iran J Public Health. 2010; 39(2): 63-8[PubMed]
  • 20. Baker C, Pradhan A, Pakstis L, Pochan Darrin J, Shah S Ismat. Synthesis and antibacterial properties of silver nanoparticles. J Nanosci Nanotechnol. 2005; 5(2): 244-249
  • 21. Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramirez JT, et al. The bactericidal effect of silver nanoparticles. Nanotechnology. 2005; 16(10): 2346-53[DOI][PubMed]
  • 22. Panáček Aleš, Kvitek Libor, Prucek Robert, Kolar Milan, Vecerova Renata, Pizurova Nadezda, et al. Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J Phys Chem B. 2006; 110(33): 16248-16253
  • 23. Shahverdi AR, Fakhimi A, Shahverdi HR, Minaian S. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomedicine. 2007; 3(2): 168-71[DOI][PubMed]
  • 24. Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci. 2004; 275(1): 177-82[DOI][PubMed]
  • 25. Hatchett David W, White Henry S. Electrochemistry of Sulfur Adlayers on the Low-Index Faces of Silver. J Phys Chem. 1996; 100(23): 9854-9859[DOI]
  • 26. Lara Humberto H, Ayala-Núnez Nilda V, Ixtepan Turrent Liliana del Carmen, Rodríguez Padilla Cristina. Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria. World J Microbiol Biotechnol. 2010; 26(4): 615-621
  • 27. Amany A, El-Rab Sanaa F Gad. Effect of reducing and protecting agents on size of silver nanoparticles and their anti-bacterial activity.
  • 28. Petrus EM, Tinakumari S, Chai LC, Ubong A, Tunung R, Elexson N, et al. A study on the minimum inhibitory concentration and minimum bactericidal concentration of Nano Colloidal Silver on food-borne pathogens. Int Food Res J. 2011; 18: 55-66
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments